Volume Spike Investor

Prana Biotechnology Ltd. (Nasdaq:PRAN) has received a key patent that will allow it to have moreprotection for its Alzheimer’s candidate.  FULL DETAILS are over at BioHealtInvestor.com.  The press release hit at 10;15 and at 10:30 AM EST we have already seen 112,000 shares trade hands compared to an average volume of about 35,000 shares.  Shares are now up 18% and almost at $2.00; the 52-week trading range is $1.00 to $4.28.  For a comparison, there was volume of 263,000 on August 5 (EU patent date) and this one spiked big by over 50% to $1.70 on over 500,000 shares back on July 10 when the company announced data showing approximately 40% of PBT2 treated patients substantially outperformed placebo patients. -JON OGG